News
Public Technologies |
11 Aug 2020
PDF Version Accurate identification of antibiotic resistance markers based on the ARESdb QIAGEN CLC Module leveraging Ares Genetics' proprietary antibiotic resistance database Pathogens correctly identified with 100% sensitivity and specificity, antibiotic resistance markers with >95% sensitivity and >99% specificity, respectively Study paves the
Public Technologies |
11 Aug 2020
Strategic Update August 2020 Legal Disclaimer This presentation includes "forward-looking statements." Such forward-looking statements are subject to a number of risks and uncertainties, many of which are not under AR's control. All statements, except for statements of historical fact, made in this presentation regarding activities,
Public Technologies |
11 Aug 2020
ICF Investor Presentation August 2020 Cautionary Statement Certain statements made by us in this presentation that are not historical facts or that relate to future plans, events, or performances are forward-looking statements within the meaning of the federal securities laws. Our actual results may differ materially from those expressed in any
Public Technologies |
11 Aug 2020
PDF Version • Obtained U.S. FDA Fast Track designation for BDTX-189 for the treatment of adult patients with a solid tumor harboring an allosteric HER2 mutation or an EGFR or HER2 Exon 20 insertion mutation • Continued to enroll and dose patients in Phase 1/2 clinical trial of BDTX-189, with Phase 1 portion on track to complete by first half of
Manila Standard Today |
11 Aug 2020
San Miguel Corporation continued to show its strong resolve to help medical frontliners in the fight against COVID-19 by recently providing medical insurance worth P2 million each to 5,000 medical workers in Cebu, which, in recent months was one of the most affected cities in the country. According to SMC president and chief operating officer Ramon
Gulf Business |
11 Aug 2020
As the Covid-19 pandemic continues to unfold, nations around the world – including those of the Gulf Cooperation Council (GCC) – remain focused on containing the spread of the virus, protecting public health, mitigating economic impact, and actioning a safe and gradual return to a “new normal.” However, until a vaccine is developed and
Omaha World-Herald |
11 Aug 2020
SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) -- The Hearing Loss Association of America (HLAA) is announcing its fall 2020 virtual Walk4Hearing events. The Walk4Hearing is raising funds for essential resources for people with hearing loss and mobilizing communities to take action for hearing health. By being active, engaged, and making hearing
Omaha World-Herald |
11 Aug 2020
Walk into the Stockton, Calfornia, city offices, and you might hear Drake's "God's Plan" coming from the mayor's office. There, Mayor Michael Tubbs could be bobbing his head to the lyrics, "I can't do this one my own, ayy, no, ayy." Outside those walls sits one of the poorest, least literate communities in the nation. And yet there's nowhere else
Odessa American |
11 Aug 2020
NEW YORK--(BUSINESS WIRE)--Aug 11, 2020-- Churchill Real Estate, a real estate investment firm focused on real estate debt, equity, and distressed opportunities in the United States, today announced it has secured $2 billion in investment capital. The investment commitment reflects the strength of the firm’s residential transition lending (RTL)
Odessa American |
11 Aug 2020
FELTHAM, England--(BUSINESS WIRE)--Aug 11, 2020-- Nomad Foods Limited (NYSE: NOMD), today announced that it has commenced the previously announced “modified Dutch auction” tender offer to purchase with cash up to $500 million of its ordinary shares, at a price per share of not less than $23.00 and not more than $25.50. The complete terms of the
Odessa American |
11 Aug 2020
MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--Aug 11, 2020-- Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today provided a clinical and business update. Evenamide “Newron has made
